baber/WOPTO huggingface dataset:
Patent AU-714191-B2 (AU)
Title: Beds
Inventor: GNJATOVIC LJUBOMIR
IPC: A47C27/10
Filed: 1997-05-23
Granted: 1999-12-23
Abstract: PCT No. PCT/GB97/01429 Sec. 371 Date Nov. 26, 1998 Sec. 102(e) Date Nov. 23, 1998 PCT Filed May 23, 1997 PCT Pub. No. WO97/45040 PCT Pub. Date Dec. 4, 1997Motorized adjustment of the configuration of a bed in its support of a user in an automatic "sleep" mode is controlled to establish the bed in state A (FIG. 3) pre-selected for sleeping on the side, or state B (FIG. 2) pre-selected for sleeping on the back, in dependence upon whether the user's shoulder as sensed by a pressure pad (26) is within a recess (27) of the mattress (1). A motor unit (8) adjusts the bed-configuration by inclining bed-base sections (4,5) under commands from a controller (15 FIG. 4) that for the "sleep" mode operates in conjunction with an auxiliary unit (16 FIG. 4) coupled to the pad (26). Delays for changeovers between states A and B and the changeover threshold are set by controls (31, 33 and 34) of the auxiliary unit (16).
Patent AU-656254-B2 (AU)
Title: Radiological imaging method
Inventor: FISHMAN ROYCE SHAWN
IPC: A61K49/00
Filed: 1993-01-14
Granted: 1995-01-27
Abstract: A radiological imaging method employing a contrast enhancement agent comprising stable xenon, oxygen and helium, for use with computerized two and three dimensional X-Ray systems and software used with said systems, in the imaging and quantitative measurement of pulmonary ventilation, patency of, distribution of and gas flow in the trachea, bronchi, bronchioles and alveoli, evaluation and optimization of respiratory therapy gas mixtures and pressures separately and in combination, liver blood flow, renal blood flow, cerebral blood flow and brain tissue function. <IMAGE>
Patent AU-726429-B2 (AU)
Title: Helicobacter pylori adhesin binding group antigen
Inventor: BOREN THOMAS
IPC: C07K14/205
Filed: 1997-06-10
Granted: 2000-11-09
Abstract: A novel Helicobacter pylori blood group antigen binding (BAB) adhesin protein was isolated and purified, whereby said protein or fractions thereof bind specifically to fucosylated blood group antigens. The protein sequence of said adhesin is disclosed in this application. Simultaneously the DNA sequences for two genes, babA and babB, producing highly similar proteins, are disclosed. Said adhesin and/or DNA is useful for diagnose and therapy and/or prophylaxis directed against H. pylori induced infections, e.g. gastritis and acid peptic disease, i.e. active vaccination. A new immunoglobulin composition, which exhibits specific activity to a Lewis<SUP>b </SUP>antigen binding Helicobacter pylori adhesin, or preferably, monoclonal and/or polyclonal antibodies to said adhesin offer a new and more efficient method of treatment and/or prevention of gastrointestinal diseases, caused by Helicobacter pylori or other Helicobacter species, i.e. passive vaccination.
Patent AU-771570-B2 (AU)
Title: A method when cleaning a filter
Inventor: BJARNO ODD
IPC: B01D46/04
Filed: 2001-01-31
Granted: 2004-03-25
Abstract: When cleaning a barrier filter, comprising a plurality of filter elements, of woven fabric of felt, arranged to separate particles out of a polluted gas, the filter elements are cleaned, separately or in groups, by pressurized air pulses, the frequency, the maximum pressure and the duration of which are varied in order to minimize, by an adjustment, the total emission of dust. The frequency and/or the maximum pressure and/or the duration of the cleaning pulses are varied for a group or a plurality of groups of filter elements. After each cleaning pulse, the maximum value for the instantaneous emission of dust, the emission peak, is determined and the emission peak is used, after cleaning a certain group of filter elements, for selecting the frequency and/or the maximum pressure and/or the duration of the cleaning pulses for this group of filter elements during continued operation.
Patent AU-608165-B2 (AU)
Title: Process for the purification of gallium by partial solidification
Inventor: POULIQUEN BENOIT
IPC: C22B58/00
Filed: 1989-06-28
Granted: 1991-03-21
Abstract: This invention relates to a process for purifying gallium by partial solidification. This process consists in locally cooling a mass of liquid gallium so as to convert it partially into crystals which are purer than the initial liquid and then compressing the said crystals to obtain a mass which is as compact as possible, which is then separated from the residual liquid and then remelted. It applies to the manufacture of gallium of purity higher than 99.9999%, meeting the specifications of the electronics industry. <IMAGE>
Patent AU-760801-B2 (AU)
Title: An insect capturing device
Inventor: ALLEN ANTHONY
IPC: A01M1/10
Filed: 1999-05-07
Granted: 2003-05-22
Abstract: The device comprises a handle (2), a head (4) having bristles (5) and an actuator to cause the bristles to surround and capture an insect (Fig 9). The bristles (5) may be arranged in concentric rings. The handle (2) may have a trigger (11) which allows a user to move the bristles (5) between a diverged position and a converged position in which an insect is entrapped without being injured. The device may then be carried outdoors and the bristles again moved to the diverged position so that the insect is released harmlessly.
Patent AU-578661-B2 (AU)
Title: Method for diagnosis of A.I.D.S.
Inventor: GROSS ROBERT L
IPC: G01N33/50
Filed: 1985-02-26
Granted: 1988-11-03
Abstract: A novel method for the diagnosis of Acquired Immune Deficiency Syndrome (A.I.D.S.) is disclosed, involving the use of immunocytoadherence (rosette inhibition) techniques. The method is based on the discovery that the lymphocytes of A.I.D.S. patients are unusually resistant to antithymocyte serum, and that the plasma of A.I.D.S. patients is capable of conferring this resistance to normal lymphocytes. Accordingly, the diagnostic method involves performing rosette inhibition tests on the patient's lymphocytes or on lymphocytes from a healthy donor after treatment with the patient's plasma. Any observable lessening of inhibition in comparison with a control is related to the presence of A.I.D.S.
Patent AU-634976-B2 (AU)
Title: Galactopyranosyl-galactopyranosyl receptor analogues
IPC: C07H15/18
Filed: 1989-08-11
Granted: 1993-03-11
Abstract: PCT No. PCT/DK89/00192 Sec. 371 Date Apr. 11, 1991 Sec. 102(e) Date Apr. 11, 1991 PCT Filed Aug. 11, 1989 PCT Pub. No. WO90/01488 PCT Pub. Date Feb. 22, 1990.A method for treating infections caused by galabiose-binding bacteria using galabiose derivatives modified at the 3' and anomeric positions. The galabiose-derivatives and compositions of same are also disclosed.
Patent AU-707160-B2 (AU)
Title: Tetrahydronaphthalene derivatives and their therapeutic use
Inventor: TAYLOR RICHARD JOHN KENNETH
IPC: A61P29/00
Filed: 1997-09-05
Granted: 1999-07-01
Abstract: Compounds of the formula wherein R1 is a fucose or mannose residue, have therapeutic utility via inhibition of selectins, and thus of cell adhesion.
Patent AU-709378-B2 (AU)
Title: Anchorage assembly
Inventor: GREEN DAVID ROBERT
IPC: E04C5/12
Filed: 1995-12-20
Granted: 1999-08-26
Abstract: The invention relates to anchorage assemblies and in particular to anchorage assemblies having a novel wedge arrangement, wedges for use with anchorage assemblies and an anchorage member. In order to improve wedge performance in an anchorage assembly, a wedge (21) is provided having both internally (24) and externally (25) relieved portions to give a nose area (26) which is tapered to a greater extent than the rest of the wedge (21). Under normal load conditions, the wedge (21) behaves like a short wedge having no nose relief and is highly efficient. However, under high load or load limit conditions, the nose portion (26) of the wedge (21) is arranged to deform plastically so that fretting of the stressing element (23) gripped by the wedge (21) does not occur. As well as the high performance wedge, an improved anchorage member for the anchorage assembly is provided, the anchorage member having a number of steps (34-74). The provision of steps (34-74) in the anchorage member reduces the tendency for anchorage members to be drawn into prestressed concrete structures and reduces the bursting forces within such structures. The combination of an anchorage assembly having the improved wedge and improved anchorage member is a particularly effective and advantageous one.
Patent AU-704224-B2 (AU)
Title: Method and composition for providing repulpable moisture vapor barrier coating for flexible packaging
Inventor: BERUBE SERGE
IPC: D21C5/02
Filed: 1996-01-17
Granted: 1999-04-15
Abstract: The composition comprises a polymer emulsion containing, for example, polyvinylidene chloride having a particle size distribution finer than 10 mu , and an additive with generally the same size distribution, for example aluminum silicte, calcium carbonate, polyvinyl acetate polystyrene, polyacrylates, in emulsion or powder form which is capable of interstitial combination with the polymer particles. The composition has a critical pH between about 2 and 7. The method of repulping coated packaging is also disclosed.
Patent AU-570819-B2 (AU)
Title: Friction-facing material
Inventor: BAKER RALPH
IPC: F16D69/02
Filed: 1985-08-08
Granted: 1988-03-24
Abstract: In a method of making asbestos-free friction facing material in the form of a water-laid sheet of cellulosic fibres, in which are distributed friction-imparting particles and particles of friction-modifier, the sheet containing a thermosetting phenolic resin which after curing binds the ingredients firmly together, the thermosetting phenolic resin is included in emulsified form in the aqueous suspension of ingredients from which the water-laid sheet is prepared. This leads to a product of more consistent friction performance than is obtained by post-sheeting impregnation with thermosetting phenolic resin.
Patent AU-614209-B2 (AU)
Title: Transdermal therapeutical system comprising physostigmine as active component and process for the production thereof
Inventor: HILLE THOMAS DR
IPC: A61L15/16
Filed: 1989-12-18
Granted: 1991-08-22
Abstract: The invention relates to a transdermal therapeutic system for administering physostigmine onto the skin, composed of a covering layer which is impermeable to the active ingredient, of an adhesive reservoir layer and, where appropriate, of a protective layer which can be detached again, a reservoir layer of which contains 10 - 90 % by weight of polymer material selected as from the groups consisting of block copolymers based on styrene and 1,3-dienes, polyisobutylenes, acrylate- and/or methacrylate-based polymers and esters of hydrogenated rosin, 0-30 % by weight of plasticisers based on hydrocarbons and/or esters and 0.1 - 20 % by weight of physostigmine.
Patent AU-728635-B2 (AU)
Title: Rolled section and process for its manufacture
Inventor: JOLLER ALBIN
IPC: C21D9/04
Filed: 1997-12-18
Granted: 2001-01-11
Abstract: A rolled profile, especially a road or railway rail, consists of an iron alloy which contains C, Si, Mn, optionally Cr, special carbide forming and transformation modifying elements and/or micro-alloying additions, balance Fe and impurities and which has a structure formed by accelerated cooling from the austenitic region. The novelty is that the iron alloy has a Si content of NOTGREATER 0.93 (preferably 0.21-0.69) wt.%, an Al content of  NOTGREATER  0.06 (preferably less than 0.03) wt.%, a total Si + Al content of less than 0.99 wt.% and, over at least parts of its cross-section along its length, a structure formed by isothermal transformation of austenite in the lower intermediate phase or lower bainitic region. Preferably, the iron alloy contains (by wt.) 0.41-1.3 (preferably 0.51-0.98) % C, 0.31-2.55 (preferably 0.91-1.95) % Mn and balance Fe, preferably with addition of 0.21-2.45 (preferably 0.38-1.95) % Cr and optionally up to 0.88 (preferably up to 0.49) % Mo, up to 1.69 (preferably up to 0. 95) % W, up to 0.39 (preferably up to 0.19) % V, up to 0.28 (preferably up to 0.19) % total of Nb, Ta, Zr, Hf and/or Ti, up to 2.4 (preferably up to 0.95) % Ni and up to 0.006 (preferably up to 0.004) % B. Also claimed is production of the above rolled profile, in which (a) the alloy composition is chosen within narrow limits which determine the transformation behaviour on cooling from the f.c.c. structure or austenitic region; and (b) the rolled profile, produced from the alloy, is cooled to between the martensite point and a temperature  NOTGREATER  250 (preferably  NOTGREATER  190, especially 5-110) degrees C above the martensite point and then allowed to transform isothermally.
Patent AU-694847-B2 (AU)
Title: Thiols to promote hematopoietic progenitor cell growth
Inventor: CAPIZZI ROBERT L
IPC: A61K31/13
Filed: 1996-02-16
Granted: 1998-07-30
Abstract: The present invention relates to methods of stimulating he growth of hematopoietic progenitor cells. In particular, it relates to the use of thiols and related compounds in stimulating the growth of hematopoietic progenitor cells in vitro and in vivo. Furthermore, the present invention relates to methods of using these compounds for the treatment of marrow failure states and immunodeficient conditions, including but not limited to myelodysplastic syndromes and acquired immunodeficiency syndrome.
Patent AU-630432-B2 (AU)
Title: Siliconized emulsion based pressure-sensitive adhesives
Inventor: LEE IVAN SOU PHONG
IPC: C08F220/10
Filed: 1990-02-20
Granted: 1992-10-29
Abstract: There is provided inherently tacky pressure-sensitive adhesive polymers prepared by emulsion polymerization and containing an interpolymerized amount of a reactive silicone acrylate polymer, an unsaturated carboxylic acid one or more alkyl acrylates, preferably a mixture of butyl acrylate and 2-ethylhexyl acrylate. Methyl acrylate and vinyl acetate are optionally present. The polymers have initial repositionability, long term permanence and excellent water resistance.
Patent AU-674032-B2 (AU)
Title: Ophthalmic lens inspection system and method
Inventor: EDWARDS RUSSELL J
IPC: G01M11/02
Filed: 1993-12-15
Granted: 1996-12-05
Abstract: A lens inspection method and apparatus is disclosed comprising a pallet having wells for receiving one or more lens containers at the receiving point. A conveyor achieves uniformity of pallet motion needed in the direction of pallet travel and stability when transporting the lens in the orthogonal, non-translating directions by use of one or more guide rails and a mechanical bias means. Pallet wells for receiving the containers comprise holes that pass through the pallet. These holes along with a side driven transport system make possible an arrangement of a lamp and camera on opposite sides of the lens for capturing an image of a lens. A computer implemented algorithm processes the digitized image according to rules set forth in a program to determine the acceptability of the lenses. A lens disposition mechanism connected to the computer uses a signal generated by the computer and indicates lens acceptability to disposition the lens by physically separating a container with an acceptable lens from an unacceptable lens. After disposition of containers, the pallet is returned by conveyor to the lens receiving point.
Patent AU-765493-B2 (AU)
Title: Pavement marking articles having enhanced retroreflectivity under wet conditions and method for making same
Inventor: HEDBLOM THOMAS P
IPC: E01F9/04
Filed: 1999-08-03
Granted: 2003-09-18
Abstract: The articles of the present invention comprise pavement marking articles which are retroreflective under dry and/or wet conditions. The articles comprise a monolayer of exposed-lens optical elements, a spacing layer, and a reflective layer. The present invention also provides a method of making said pavement marking articles.
Patent AU-709658-B2 (AU)
Title: Aqueous dispersions of transparent powder coating
Inventor: SACHARSKI LAWRENCE
IPC: C09D5/46
Filed: 1996-04-04
Granted: 1999-09-02
Abstract: The invention concerns an aqueous dispersion of a transparent coating powder, the dispersion consisting of a solid, powder-form component (A) and an aqueous component (B). Component A is a transparent coating powder containing a) at least one epoxy-containing binder having from 30 to 45 %, preferably 30 to 35 %, of glucidyl-containing monomers optionally containing vinyl aromatic compounds, preferably styrene, b) at least one cross-linking agent, preferably staight-chain, aliphatic dicarboxylic acids and/or carboxy-function polyesters, and optionally c) catalysts, auxiliaries and additives typical of coating powders such as degassing agents, flow agents, UV absorbers, radical-capture agents and anti-oxidants. Component B is an aqueous dispersion containing a) at least one non-ionic thickening agent, preferably a non-ionic associative thickener, and optionally b) catalysts, auxiliaries, anti-foaming agents, dispersing agents, wetting agents, preferably carboxy-function dispersing agents, anti-oxidants, UV absorbers, radical-capture agents, biocides and small amounts of solvents and/or water-retention agents. The invention also concerns a method of manufacturing a dispersion of this kind and its use on automobile bodywork.
Patent AU-629929-B2 (AU)
Title: Acetylated heterologous polypeptides
Inventor: BRUNNER DAVID PAUL
IPC: C12R1/19
Filed: 1990-01-23
Granted: 1992-10-15
Abstract: An animal somatotropin which has at least one lysine residue corresponding to residues 157, 167, 171 or 180 of the native somatotropin sequence replaced by arginine or glutamine.
Patent AU-726556-B2 (AU)
Title: A long acting injectable parasiticidal composition and the process for its preparation
Inventor: LAMBERTI JORGE CARLOS
IPC: A61K47/10
Filed: 1998-03-18
Granted: 2000-11-09
Abstract: Injectable, long acting parasiticidal composition which comprises enough ivermectin to achieve a final concentration of about 1% (w/w), benzilic alcohol, polyvinylpyrrolidone, N-metyl-2-pyrrolidone in a 40-65% proportion (v/w) of the total formulation and glycerin until completing final 100% weight. The process for its preparation involves mixing enough ivermectin to obtain a final concentration of about 1% (w/w) with benzilic alcohol and polyvinylpyrrolidone followed by the addition of the mixture to N-metyl-2-pyrrolidone, the latter in a 40-65% proportion (v/w) of the total of the formulation. The mixture is shaken until totally dissolved and glycerin is added until reaching 100% final weight.
Patent AU-685436-B2 (AU)
Title: Vacuum compensation valve
Inventor: PITTMAN JAMES
IPC: A47L9/00
Filed: 1994-03-25
Granted: 1998-01-22
Abstract: PCT No. PCT/CA94/00157 Sec. 371 Date Sep. 26, 1995 Sec. 102(e) Date Sep. 26, 1995 PCT Filed Mar. 25, 1994 PCT Pub. No. WO94/22355 PCT Pub. Date Oct. 13, 1994Apparatus for vacuum collection of material, where a vacuum source is used for creating a vacuum to draw air into a displacement chamber, and at least two hoses are connected to the displacement chamber for vacuum collection of materials from various locations. Pressure sensors are connected to sense pressure in each hose, dampers are operable in response to the relative pressures between the hoses so as to vary the effective area of the respective connections between the hoses and the displacement chamber in order to equalize and optimize the relative pressures, and an automatic control such as a programmable logic controller is employed to operate the dampers in response to said sensed pressures.
Patent AU-782277-B2 (AU)
Title: Method of controlling body temperature while reducing shivering
Inventor: DAE MICHAEL W
IPC: A61P25/00
Filed: 2000-07-26
Granted: 2005-07-14
Abstract: A method and apparatus for lowering the body temperature of a patient while reducing shivering by using a heat exchange device in combination with an alpha2-adrenoreceptor agonist, a non-opiod analgesic monoamine uptake inhibitor or neuropeptide that temporarily reduces shivering. The devices disclosed include a catheter having a heat exchange balloon thereon with heat exchange fluid circulating through the interior of the balloon. The heat exchange balloon is placed in the vasculature of a patient, and heat exchange fluid at a temperature other than the temperature of the blood in the vasculature is circulated through the interior of the balloon to add or remove heat from the blood of the patient. Various alpha2-adrenoreceptor agonistalpha2-adrenoreceptor agonists, non-opiod analgesic monoamine uptake inhibitors and neuropeptides are disclosed including dexmedetomidine, nefopam, neurotensin and anticonvulsant medications and pharmaceutically acceptable salts thereof. A control system for the control of the patient's temperature is disclosed for controlling the patient's temperature in conjunction with administering the alpha2-adrenoreceptor agonist, non-opiod analgesic monoamine uptake inhibitor or neuropeptide.
Patent AU-715733-B2 (AU)
Title: Method of preventing animal diseases and promoting animal growth and development
Inventor: ZHAN YONG
IPC: C07H15/00
Filed: 1996-08-16
Granted: 2000-02-10
Abstract: A method of promoting growth and improving imumune function of animals is described in the present invention, in which a bioactive agent extracted from seed cake is used as feed additive.
Patent AU-679070-B2 (AU)
Title: The removal of mercury from cracker feed
Inventor: BONTE GEERT IMELDA VALERE
IPC: C10G32/02
Filed: 1994-04-29
Granted: 1997-06-19
Abstract: The invention relates to a process for the removal of mercury and/or other heavy metals from a cracker feed with the aid of an adsorbent. The process is characterized in that the feed is also subjected to magnetic filtration.
Patent AU-675140-B2 (AU)
Title: Aluminosilicates
Inventor: ARAYA ABRAHAM
IPC: C01B39/28
Filed: 1994-04-28
Granted: 1997-01-23
Abstract: Sodium silicate, sodium aluminate and sodium hydroxide are mixed together to produce a gel having the general formula: 2.5-7.5 Na2O, 2.2-3.0 SiO2, Al2O3, 80-250 H2O and a volume of more than 1.5 m<3>, no XRD detectable zeolite A being produced and no zeolite P being added, the product being eventually filtered, washed and dried. It is thus possible to produce on an industrial scale an alkali metal aluminosilicate of zeolite P type having the oxide formula: M2/nO, Al2O3, 2.0-2.66 SiO2, y H2O.
Patent AU-698553-B2 (AU)
Title: Parallel primer extension approach to nucleic acid sequence analysis
Inventor: CASKEY C THOMAS
IPC: C12Q1/6858
Filed: 1994-06-22
Granted: 1998-10-29
Abstract: A method of analyzing a polynucleotide of interest, comprising providing one or more sets of consecutive oligonucleotide primers differing within each set by one base at the growing end thereof; annealing a single strand of the polynucleotide or a fragment of the polynucleotide to the oligonucleotide primers under hybridization conditions; subjecting the primers to single base extension reactions with a polymerase and terminating nucleotides, the terminating nucleotides being mutually distinguishable; and observing the location and identity of each terminating nucleotide to thereby analyze the sequence or a part of the nucleotide sequence of the polynucleotide of interest, is disclosed. An apparatus comprising a solid support to which is attached at defined locations thereon one or more sets of consecutive oligonucleotide primers differing within each set by one base at the growing end thereof is also described.